Advertisement

The Journal of Physiological Sciences

, Volume 69, Issue 2, pp 409–419 | Cite as

Different doses of methamphetamine alter long-term potentiation, level of BDNF and neuronal apoptosis in the hippocampus of reinstated rats

  • Siamak Shahidi
  • Alireza Komaki
  • Reihaneh SadeghianEmail author
  • Sara Soleimani Asl
Original Paper
  • 31 Downloads

Abstract

Methamphetamine (METH) is a psychostimulant. The precise mechanisms of its effects remain unknown and current relapse treatments have low efficacy. However, brain-derived neurotrophic factor (BDNF) and neuronal plasticity are essential contributors, despite paradoxical reports and a lack of comprehensive studies. Therefore, we investigated the effects of different doses of METH on long-term potentiation (LTP), BDNF expression and neuronal apoptosis in the hippocampus of reinstated rats. Rats were injected intraperitoneally with METH (1, 5, or 10 mg/kg) or saline, and trained in a conditioned place preference paradigm. Following implementation of the reinstatement model, electrophysiology, western blotting and TUNEL assay were performed to assess behavior, LTP components, BDNF expression, and neuronal apoptosis, respectively. The results demonstrated that the preference scores, population spike amplitude and BDNF expression markedly decreased in the METH (10 mg/kg) group compared with the other groups. In contrast, METH (5 mg/kg) significantly increased these factors more than the control group. There was no change in variables between METH (1 mg/kg) and the control group. Also, apoptosis of the hippocampus was increased in the METH (10 mg/kg) group compared with the METH (5 mg/kg) group. These results suggest that alterations in synaptic plasticity, expression of BDNF and neuronal apoptosis in the hippocampus has a vital role in the context-induced reinstatement of METH seeking.

Keywords

Reinstatement Conditioned place preference Long-term potentiation Brain derived neurotrophic factor Neuronal apoptosis Methamphetamine 

Notes

Acknowledgements

We thank Drug Control Headquarters of the Police, Hamadan, Iran, the vice-chancellor for Research and Technology, Hamadan University of Medical Sciences (no. 9407073722), and the Cognitive Science and Technologies Council (no. 3078), Tehran, who supported this study in the provision of equipment and supplies.

Compliance with ethical standards

Conflict of interest

The authors declare that there is no conflict of interest for any of them.

Ethical approval

All animal experimental procedures were performed in accordance with the guidelines for proper conduct of animal experiments issued by the Ethics Committee of the Hamadan University of Medical Sciences (IR.Umsha.REC.1394.200), and performed according to The Guide for Care and Use of Laboratory Animals published by the National Institutes of Health, United States (NIH Publication No. 85-23, revised 1985).

References

  1. 1.
    Bamford NS et al (2008) Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration. Neuron 58(1):89–103Google Scholar
  2. 2.
    Shahidi S, Hasanein P (2011) Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms. Brain Res Bull 86(1–2):118–122Google Scholar
  3. 3.
    Rogers JL, De Santis S, See RE (2008) Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology 199(4):615–624Google Scholar
  4. 4.
    Napier TC, Herrold AA, de Wit H (2013) Using conditioned place preference to identify relapse prevention medications. Neurosci Biobehav Rev 37:2081–2086Google Scholar
  5. 5.
    Fuchs RA et al (2008) Relapse to drug seeking following prolonged abstinence: the role of environmental stimuli. Drug Discov Today Dis Models 5(4):251–258Google Scholar
  6. 6.
    Choi S et al (2017) Noradrenergic inhibition of spinal hyperexcitation elicited by cutaneous cold stimuli in rats with oxaliplatin-induced allodynia. Electrophysiol Behav Asses 67(3):431–438Google Scholar
  7. 7.
    Yahyavi-Firouz-Abadi N, See RE (2009) Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol Ther 124(2):235–247Google Scholar
  8. 8.
    Pickens CL et al (2011) Neurobiology of the incubation of drug craving. Trends Neurosci 34(8):411–420Google Scholar
  9. 9.
    Hammad AM et al (2017) Modulatory effects of ampicillin/sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior. Behav Brain Res 332:288–298Google Scholar
  10. 10.
    Siahposht-Khachaki A et al (2017) Involvement of AMPA/kainate glutamate receptor in the extinction and reinstatement of morphine-induced conditioned place preference: a behavioral and molecular study. Cell Mol Neurobiol 37(2):315–328Google Scholar
  11. 11.
    Briand LA et al (2016) Disrupting GluA2 phosphorylation potentiates reinstatement of cocaine seeking. Neuropharmacology 111:231–241Google Scholar
  12. 12.
    Thompson AM et al (2004) Modulation of long-term potentiation in the rat hippocampus following cocaine self-administration. Neuroscience 127(1):177–185Google Scholar
  13. 13.
    Keleta YB, Martinez JL (2012) Brain circuits of methamphetamine place reinforcement learning: the role of the hippocampus-VTA loop. Brain Behav 2(2):128–141Google Scholar
  14. 14.
    Recinto P et al (2012) Levels of neural progenitors in the hippocampus predict memory impairment and relapse to drug seeking as a function of excessive methamphetamine self-administration. Neuropsychopharmacology 37(5):1275–1287Google Scholar
  15. 15.
    Azizi-Malekabadi H et al (2012) Different effects of scopolamine on learning, memory, and nitric oxide metabolite levels in hippocampal tissues of ovariectomized and sham-operated rats. Arq Neuropsiquiatr 70(6):447–452Google Scholar
  16. 16.
    Sadeghian R et al (2012) Decreased nitric oxide levels in the hippocampus may play a role in learning and memory deficits in ovariectomized rats treated by a high dose of estradiol. Arq Neuropsiquiatr 70(11):874–879Google Scholar
  17. 17.
    Ricoy UM, Martinez JL Jr (2009) Local hippocampal methamphetamine-induced reinforcement. Front Behav Neurosci 3:47Google Scholar
  18. 18.
    Rogers JL, See RE (2007) Selective inactivation of the ventral hippocampus attenuates cue-induced and cocaine-primed reinstatement of drug-seeking in rats. Neurobiol Learn Memory 87(4):688–692Google Scholar
  19. 19.
    Sun W, Rebec GV (2003) Lidocaine inactivation of ventral subiculum attenuates cocaine-seeking behavior in rats. J Neurosci 23(32):10258–10264Google Scholar
  20. 20.
    Chambers RA, Self DW (2002) Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia. Neuropsychopharmacology 27(6):889–905Google Scholar
  21. 21.
    Kim DJ et al (2005) High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett 388(2):112–115Google Scholar
  22. 22.
    Russo SJ et al (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56:73–82Google Scholar
  23. 23.
    Chen PH et al (2014) Serum brain-derived neurotrophic factor levels were reduced during methamphetamine early withdrawal. Addict Biol 19(3):482–485Google Scholar
  24. 24.
    Hajheidari S et al (2017) Effects of prolonged abstinence from METH on the hippocampal BDNF levels, neuronal numbers and apoptosis in methamphetamine-sensitized rats. Neurosci Lett 645:80–85Google Scholar
  25. 25.
    Castren E, Antila H (2017) Neuronal plasticity and neurotrophic factors in drug responses. Mol Psychiatry 22(8):1085–1095Google Scholar
  26. 26.
    Korte M et al (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92(19):8856–8860Google Scholar
  27. 27.
    Swant J et al (2010) Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. PLoS One 5(6):e11382Google Scholar
  28. 28.
    Walz C et al (2006) Presynaptic plasticity in an immature neocortical network requires NMDA receptor activation and BDNF release. J Neurophysiol 96(6):3512–3516Google Scholar
  29. 29.
    da Silveira FP et al (2017) BDNF levels are increased in peripheral blood of middle-aged amateur runners with no changes on histone H4 acetylation levels. J Physiol Sci 67(6):681–687Google Scholar
  30. 30.
    Thompson AM, Swant J, Wagner JJ (2005) Cocaine-induced modulation of long-term potentiation in the CA1 region of rat hippocampus. Neuropharmacology 49(2):185–194Google Scholar
  31. 31.
    Baharlouei N et al (2015) Blockage of acquisition and expression of morphine-induced conditioned place preference in rats due to activation of glutamate receptors type II/III in nucleus accumbens. Pharmacol Biochem Behav 135:192–198Google Scholar
  32. 32.
    Roohi N et al (2014) Microinjection of the mGluR5 antagonist MTEP into the nucleus accumbens attenuates the acquisition but not expression of morphine-induced conditioned place preference in rats. Pharmacol Biochem Behav 126:109–115Google Scholar
  33. 33.
    Abulseoud OA et al (2012) Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm. Brain Res 1456:14–21Google Scholar
  34. 34.
    Zarepour L et al (2013) Potentiation of rewarding properties of morphine by concurrent chemical stimulation of lateral hypothalamus in rats. Pharmacol Biochem Behav 107:36–41Google Scholar
  35. 35.
    Arezoomandan R et al (2016) Administration of activated glial condition medium in the nucleus accumbens extended extinction and intensified reinstatement of methamphetamine-induced conditioned place preference. Brain Res Bull 125:106–116Google Scholar
  36. 36.
    Attarzadeh-Yazdi G, Arezoomandan R, Haghparast A (2014) Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat. Prog Neuropsychopharmacol Biol Psychiatry 53:142–148Google Scholar
  37. 37.
    Cass WA (1997) Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J Pharmacol Exp Ther 280(1):105–113Google Scholar
  38. 38.
    Itzhak Y, Ali SF (1996) The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 67(4):1770–1773Google Scholar
  39. 39.
    Sim MS et al (2017) MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens. Metab Brain Dis 32(6):1767–1783Google Scholar
  40. 40.
    Heysieattalab S et al (2016) Methamphetamine-induced enhancement of hippocampal long-term potentiation is modulated by NMDA and GABA receptors in the shell-accumbens. Synapse 70(8):325–335Google Scholar
  41. 41.
    Alshehri FS, Althobaiti YS, Sari Y (2017) Effects of administered ethanol and methamphetamine on glial glutamate transporters in rat striatum and hippocampus. J Mol Neurosci 61(3):343–350Google Scholar
  42. 42.
    Bowyer JF et al (2017) Corticosterone and exogenous glucose alter blood glucose levels, neurotoxicity, and vascular toxicity produced by methamphetamine. J Neurochem 143(2):198–213Google Scholar
  43. 43.
    Vatankhah M et al (2018) AMN082-a metabotropic glutamate receptor type 7 allosteric agonist in the NAc facilitates extinction and inhibits the reinstatement of morphine-induced conditioned place preference in male rats. Brain Res Bull 140:28–33Google Scholar
  44. 44.
    Meng S et al (2014) Effect of baclofen on morphine-induced conditioned place preference, extinction, and stress-induced reinstatement in chronically stressed mice. Psychopharmacology 231(1):27–36Google Scholar
  45. 45.
    Shahidi S et al (2018) Effect of a 5-HT1D receptor agonist on the reinstatement phase of the conditioned place preference test and hippocampal long-term potentiation in methamphetamine-treated rats. Brain Res 1698:151–160Google Scholar
  46. 46.
    Shahidi S et al (2018) The effect of chronic stimulation of serotonin receptor type 7 on recognition, passive avoidance memory, hippocampal long-term potentiation, and neuronal apoptosis in the amyloid beta protein treated rat. Psychopharmacology 235(5):1513–1525Google Scholar
  47. 47.
    Hashemi-Firouzi N et al (2017) The effects of the 5-HT7 receptor on hippocampal long-term potentiation and apoptosis in a rat model of Alzheimer’s disease. Brain Res Bull 135:85–91Google Scholar
  48. 48.
    Salehi I et al (2015) Effects of vitamin E on lead-induced impairments in hippocampal synaptic plasticity. Brain Res 1629:270–281Google Scholar
  49. 49.
    Karamian R et al (2015) Vitamin C reverses lead-induced deficits in hippocampal synaptic plasticity in rats. Brain Res Bull 116:7–15Google Scholar
  50. 50.
    Lashgari R et al (2008) Effects of reversible inactivation of locus coeruleus on long-term potentiation in perforant path-DG synapses in rats. Neurobiol Learn Mem 90(2):309–316Google Scholar
  51. 51.
    Rahimi A et al (2018) Sublethal concentration of H2O2 enhances the protective effect of mesenchymal stem cells in rat model of spinal cord injury. Biotechnol Lett 40(3):609–615Google Scholar
  52. 52.
    Beheshti F et al (2019) The effects of aminoguanidine on hippocampal cytokines, amyloid beta, brain-derived neurotrophic factor, memory and oxidative stress status in chronically lipopolysaccharide-treated rats. Cytokine 113:347–355Google Scholar
  53. 53.
    Afshar S et al (2018) The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in streptozotocin-induced memory deficits in male rats. Psychopharmacology 235(10):2809–2822Google Scholar
  54. 54.
    Lu Y, Christian K, Lu B (2008) BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiol Learn Mem 89(3):312–323Google Scholar
  55. 55.
    Ying SW et al (2002) Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 22(5):1532–1540Google Scholar
  56. 56.
    Komaki A et al (2007) Effects of GABAergic inhibition on neocortical long-term potentiation in the chronically prepared rat. Neurosci Lett 422(3):181–186Google Scholar
  57. 57.
    Shen YL et al (2014) Elevated BDNF mRNA expression in the medial prefrontal cortex after d-amphetamine reinstated conditioned place preference in rats. Neuroscience 263:88–95Google Scholar
  58. 58.
    Graham DL et al (2007) Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 10(8):1029–1037Google Scholar
  59. 59.
    Corominas M et al (2007) Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction. Neuropsychobiology 55(1):2–13Google Scholar
  60. 60.
    Berglind WJ et al (2007) A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci 26(3):757–766Google Scholar
  61. 61.
    Pu L, Liu QS, Poo MM (2006) BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat Neurosci 9(5):605–607Google Scholar
  62. 62.
    Lu L et al (2004) A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 24(7):1604–1611Google Scholar
  63. 63.
    Dragunow M et al (1993) Brain-derived neurotrophic factor expression after long-term potentiation. Neurosci Lett 160(2):232–236Google Scholar
  64. 64.
    da Silva Moreira, Santos A, Kelly JP, Doyle KM (2017) Dose-dependent effects of binge-like methamphetamine dosing on dopamine and neurotrophin levels in rat brain. Neuropsychobiology 75(2):63–71Google Scholar
  65. 65.
    Cadet JL, Jayanthi S, Deng X (2003) Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. Faseb J 17(13):1775–1788Google Scholar
  66. 66.
    Matsuzaki H et al (2004) Brain-derived neurotrophic factor rescues neuronal death induced by methamphetamine. Biol Psychiat 55(1):52–60Google Scholar
  67. 67.
    Bobadilla AC, Garcia-Keller C, Chareunsouk V, Hyde J, Camacho DM, Heinsbroek JA, Kalivas PW (2018) Accumbens brain-derived neurotrophic factor (BDNF) transmission inhibits cocaine seeking. Addict Biol.  https://doi.org/10.1111/adb.12638 Google Scholar
  68. 68.
    Mao LM, Fibuch EE, Wang JQ (2010) Decoding BDNF-LTP coupling in cocaine addiction. Neuron 67(5):679–681Google Scholar
  69. 69.
    Smith DA, Browning M, Dunwiddie TV (1993) Cocaine inhibits hippocampal long-term potentiation. Brain Res 608(2):259–265Google Scholar
  70. 70.
    Soloviev A et al (2010) Electrophysiological and contractile evidence of the ability of human mesenchymal stromal cells to correct vascular malfunction in rats after ionizing irradiation. J Physiol Sci 60(2):161–172Google Scholar
  71. 71.
    Niwa M et al (2018) Electrophysiological properties of Ia excitation and recurrent inhibition in cat abdominal motoneurons. J Physiol Sci 6:1–10Google Scholar
  72. 72.
    Figurov A et al (1996) Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381(6584):706–709Google Scholar
  73. 73.
    Kang H et al (1997) Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation. Neuron 19(3):653–664Google Scholar
  74. 74.
    Deng X et al (2001) Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Mol Brain Res 93(1):64–69Google Scholar
  75. 75.
    Zhu JPQ, Xu W, Angulo JA (2006) Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience 140(2):607–622Google Scholar

Copyright information

© The Physiological Society of Japan and Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Neurophysiology Research CenterHamadan University of Medical SciencesHamadanIran
  2. 2.Medical Toxicology and Drug Abuse Research CenterBirjand University of Medical SciencesBirjandIran
  3. 3.Anatomy Departments, School of MedicineHamadan University of Medical SciencesHamadanIran

Personalised recommendations